Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 11 EP applications Johann Then has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11729733

HEXAFLUOROISOPROPYL CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

IPC classification:
A61K 31/4468, A61P 25/00, C07D 205/04, C07D 207/12, C07D 207/14, C07D 211/16, C07D 211/46, C07D 211/54, C07D 211/58, C07D 211/62, C07D 401/12, C07D 403/04, C07D 405/12, C07D 409/12, C07D 413/12
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Mylène Audrey Séverine Quellari, Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP13151034

Oxazolopyrimidines as Edg-1 receptor agonists

IPC classification:
A61K 31/519, A61P 9/10, C07D 498/04, C07D 519/00
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP11733622

ARYLOXY-ALKYLENE SUBSTITUTED HYDROXYPHENYL HEXYNOIC ACIDS, METHODS FOR THE PRODUCTION THEREOF AND USE OF THE SAME AS MEDICAMENT

IPC classification:
A61K 31/192, A61K 31/44, C07C 59/64, C07C 255/54, C07D 213/65
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP12790551

CRYSTALLINE SALTS OF R)-3-[6-AMINO-PYRIDIN-3-YL]-2-(1-CYCLOHEXYL-1H-IMIDAZOL-4-YL)-PROPIONIC ACID

IPC classification:
A61K 31/4439, A61P 7/02, C07D 401/06
Applicant:
Sanofi, S.A.
Agent:
Michalski Hüttermann & Partner
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12791162

SODIUM SALT OF (R)-3-[6-AMINO-PYRIDIN-3-YL]-2-(1-CYCLOHEXYL-1H-IMIDAZOL-4-YL)-PROPIONIC ACID

IPC classification:
A61K 31/4439, A61P 7/02, C07D 401/06
Applicant:
Sanofi, S.A.
Agent:
Michalski Hüttermann & Partner
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12788550

SALT OF (R)-3-(6-AMINO-PYRIDIN-3-YL)-2-(1-CYCLOHEXYL-1H-IMIDAZOL-4-YL) ETHYL PROPIONATE

IPC classification:
A61K 31/4439, A61P 7/02, C07D 401/06
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13305762

Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9

IPC classification:
C07K 16/40
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP13306436

Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9

IPC classification:
A61K 39/00, C07K 16/40
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP11731315

(2-ARYLOXY-ACETYLAMINO)-PHENYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS MEDICAMENT

IPC classification:
A61K 31/196, A61K 31/277, A61P 3/10, C07C 235/24, C07C 255/44
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11779661

PROCESS FOR THE PREPARATION OF 3-(6-AMINO-PYRIDIN-3YL)-2-ACRYLIC ACID DERIVATIVES

IPC classification:
C07D 233/64, C07D 233/84
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11729315

SPIROCYCLICALLY SUBSTITUTED 1,3-PROPANE DIOXIDE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND USE OF THE SAME AS MEDICAMENT

IPC classification:
A61K 31/192, A61K 31/34, A61K 31/381, A61K 31/421, A61K 31/426, A61K 31/4439, C07C 59/72, C07C 255/54, C07D 213/64, C07D 213/65, C07D 305/06
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature